Innate and adaptive immunity in inflammatory bowel disease.
about
Type I interferons for induction of remission in ulcerative colitisThe role for protein tyrosine phosphatase non-receptor type 22 in regulating intestinal homeostasisInflammatory bowel disease related innate immunity and adaptive immunityThe intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directionsInnate Sensing of the Gut Microbiota: Modulation of Inflammatory and Autoimmune DiseasesTherapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel DiseaseAnimal models to study acute and chronic intestinal inflammation in mammalsIntestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease PathogenesisInflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological TreatmentsContribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel diseasePathophysiological role of guanylate-binding proteins in gastrointestinal diseasesInflammatory Potential of Diet and Risk of Ulcerative Colitis in a Case-Control Study from IranFood-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colonA Type III Effector NleF from EHEC Inhibits Epithelial Inflammatory Cell Death by Targeting Caspase-4Strontium chloride: can it be a new treatment option for ulcerative colitis?The PSMP-CCR2 interactions trigger monocyte/macrophage-dependent colitis.Adipose-tissue and intestinal inflammation - visceral obesity and creeping fatSmall and Long Regulatory RNAs in the Immune System and Immune DiseasesMicroRNAs: new players in IBD.Distinct patterns of IgG and IgA against food and microbial antigens in serum and feces of patients with inflammatory bowel diseasesSIGNR3-dependent immune regulation by Lactobacillus acidophilus surface layer protein A in colitis.Cyclooxygenase-2 silencing for the treatment of colitis: a combined in vivo strategy based on RNA interference and engineered Escherichia coli.Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis.The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs).Associations between CD24 gene polymorphisms and inflammatory bowel disease: A meta-analysis.Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response.How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal PathologyMiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis.Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice.Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages.Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel DiseasesOverexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.Advancing the use of Lactobacillus acidophilus surface layer protein A for the treatment of intestinal disorders in humans.WNT5A transforms intestinal CD8αα⁺ IELs into an unconventional phenotype with pro-inflammatory features.Oral Serum-Derived Bovine Immunoglobulin/Protein Isolate Has Immunomodulatory Effects on the Colon of Mice that Spontaneously Develop Colitis.Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis.B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3.MicroRNAs Classify Different Disease Behavior Phenotypes of Crohn's Disease and May Have Prognostic Utility.Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease.
P2860
Q24187202-5E8DCB7E-DB73-425B-8E67-CCEEA8354440Q26741130-14398C1B-AFB0-4EE4-B094-8B67357EF172Q26741407-77624C1A-D591-4D29-90E1-3B1E77C7B72EQ26745700-BE85F696-1C55-426B-9FC5-B5013B67B2DEQ26765847-F040197D-7021-44B8-B239-B098278B525CQ26771122-4D3E7543-AED7-4044-8166-54833D81F668Q26777430-5159A46D-E55F-4402-92D4-81B4DBECFF6CQ26781239-337BDB20-5505-4D84-838A-7CB39BE8304DQ26785537-DBCE1160-5AF2-4D25-B464-0DF9CDBA4637Q27027429-BC035936-7FBD-49F3-8F0E-0EE9BFBE3117Q28078361-819F3954-87CC-48F0-AE90-F7845EA09F10Q28395360-019A6CBA-F5FD-49D7-9072-308E3E5EA37BQ29248437-4D93EF9B-99C4-4E4A-AA6C-06A5B91A12A2Q33737576-BC99FF3C-0E9A-4732-8639-C3A2AB335C1AQ33861835-6CB2ADCD-A298-41F8-932A-E354B49B5E46Q33895126-9747B092-B2E4-420D-92ED-B7C8463BF5A3Q34239249-48995F5E-7D8D-4CD3-B67F-FF73554DCFB8Q34368789-3086DC60-5723-4686-A682-48704F007102Q35135542-A5537F51-7D3E-4A5C-AA7B-2E73C9F9E0C9Q35249872-0DEA7C2B-52B7-4551-BA97-BB2637153A37Q35302843-98743158-E59A-4A4C-8D40-73B5FDC0AA46Q35417757-D9A7D6D5-A8EC-44F7-8723-37DC4337EB0DQ35564093-6F8938E8-1AEB-42CC-B87E-0E1DC1EF12E1Q35610857-DC6C83A3-AD7C-462E-BAB0-1A19BAABF17CQ35644310-F72ADE46-AE4B-43AE-AE66-00BE5E0F5235Q35661537-A41B58E2-D9D6-4F06-9164-D4DE103F8415Q35668249-6970846D-5285-4432-BB1D-7F4586EF7AD4Q35681510-3A7A6206-218E-47FD-92B8-AD376C2A7317Q35686196-5E6BD03E-D285-4522-83A8-67AEA492D0B9Q35706636-CC768630-4274-4E7E-AB36-B452F6546312Q35755739-589065CC-8C54-4B05-949C-1028A9F02149Q35819537-D7003681-90C8-463A-A06D-6A50E06D9104Q35863635-6A51410B-20B2-47AF-BBEF-7F58C3925E75Q35864859-A3187CFD-AB37-427C-822C-A67ECE662F0CQ36006728-CD82ECAB-0D2E-453F-853A-4F59720F516FQ36010505-5CE4968B-C4DA-4CC2-BBAD-0E4EAA1BE451Q36088901-ED192112-B230-4394-ADD4-6B1D37588F5BQ36123262-F6D653FC-E341-4996-9D58-721FAA838A10Q36155959-BA1C9F56-FA56-4CF2-BCB0-B6F5F7088776Q36221213-53F0D7E9-78AC-43A9-A01E-91AA72998CE1
P2860
Innate and adaptive immunity in inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Innate and adaptive immunity in inflammatory bowel disease.
@en
type
label
Innate and adaptive immunity in inflammatory bowel disease.
@en
prefLabel
Innate and adaptive immunity in inflammatory bowel disease.
@en
P50
P1433
P1476
Innate and adaptive immunity in inflammatory bowel disease
@en
P2093
Alessandra Geremia
Paolo Biancheri
P356
10.1016/J.AUTREV.2013.06.004
P577
2013-06-15T00:00:00Z